State of Wisconsin Investment Board’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-19,306
| Closed | -$3.32M | – | 2280 |
|
|
2021
Q3 | $3.32M | Buy |
19,306
+312
| +2% | +$40.8K | 0.01% | 1162 |
|
|
2021
Q2 | $2.38M | Sell |
18,994
-219
| -1% | -$27.6K | ﹤0.01% | 1242 |
|
|
2021
Q1 | $2.6M | Sell |
19,213
-102
| -0.5% | -$13.2K | 0.01% | 1180 |
|
|
2020
Q4 | $2.47M | Sell |
19,315
-28,662
| -60% | -$3.36M | 0.01% | 1164 |
|
|
2020
Q3 | $5.4M | Buy |
47,977
+41,347
| +624% | +$4.12M | 0.01% | 911 |
|
|
2020
Q2 | $632K | Sell |
6,630
-62,870
| -90% | -$6.06M | ﹤0.01% | 1358 |
|
|
2020
Q1 | $6.25M | Buy |
69,500
+2,200
| +3% | +$171K | 0.02% | 689 |
|
|
2019
Q4 | $3.57M | Hold |
67,300
| – | – | 0.01% | 1026 |
|
|
2019
Q3 | $2.66M | Buy |
67,300
+4,000
| +6% | +$174K | 0.01% | 972 |
|
|
2019
Q2 | $2.6M | Buy |
63,300
+10,300
| +19% | +$426K | 0.01% | 974 |
|
|
2019
Q1 | $2.47M | Buy |
53,000
+13,100
| +33% | +$575K | 0.01% | 964 |
|
|
2018
Q4 | $1.74M | Buy |
39,900
+500
| +1% | +$25K | 0.01% | 997 |
|
|
2018
Q3 | $2.25M | Hold |
39,400
| – | – | 0.01% | 1019 |
|
|
2018
Q2 | $1.91M | Buy |
39,400
+1,600
| +4% | +$58.3K | 0.01% | 1002 |
|
|
2018
Q1 | $1.48M | Buy |
37,800
+14,800
| +64% | +$629K | ﹤0.01% | 1024 |
|
|
2017
Q4 | $976K | Hold |
23,000
| – | – | ﹤0.01% | 1126 |
|
|
2017
Q3 | $858K | Hold |
23,000
| – | – | ﹤0.01% | 1146 |
|
|
2017
Q2 | $699K | Buy |
+23,000
| New | +$666K | ﹤0.01% | 1184 |
|
State of Wisconsin Investment Board's XLRN Position: Q4 2021 in Review
State of Wisconsin Investment Board sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 19,306 shares — an estimated $3.32M sold.
State of Wisconsin Investment Board first reported a position in XLRN in Q2 2017 and held it in 18 quarters. The position peaked at $6.25M in Q1 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- State of Wisconsin Investment Board reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- State of Wisconsin Investment Board sold 19,306 Acceleron Pharma shares in Q4 2021, an estimated $3.32M.
- State of Wisconsin Investment Board first reported a position in Acceleron Pharma in Q2 2017 and held it in 18 quarters.
- State of Wisconsin Investment Board's Acceleron Pharma position peaked at $6.25M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.